Clinical Trial

Phase 1 Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Injection of Cisplatin for Stage IV Lung Cancer

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The goal of the study is to identify the maximum tolerated dose of endobronchial ultrasound-guided transbronchial injection (EBUS-TBNI) of cisplatin for Stage IV lung cancer.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-03-14; most recent amendment 2025-10-29.
Status change: Recruiting → Active, Not Recruiting 2025-10-29
Trial Details
NCT Number NCT04311762
Lead Sponsor University of Vermont
Collaborators: University of Vermont Medical Center
Conditions Lung Cancer Metastatic
Enrollment 16 participants
Start Date 2020-02-01
Primary Completion 2029-03-01 (estimated)
Study Completion 2029-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-31